{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:28:18Z","timestamp":1790256498455,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ijantimicag.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T06:21:30Z","timestamp":1552544490000},"page":"663-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii"],"prefix":"10.1016","volume":"53","author":[{"given":"Varsha M.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Ashcraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Pankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia","volume":"30","author":"Hsu","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0002","doi-asserted-by":"crossref","first-page":"ofx176","DOI":"10.1093\/ofid\/ofx176","article-title":"Prevalence of carbapenem-resistant Gram-negative infections in the United States predominated by Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"4","author":"Cai","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0003","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","article-title":"Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing","volume":"30","author":"Lim","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0004","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/AAC.01464-06","article-title":"Global challenge of multidrug-resistant Acinetobacter baumannii","volume":"51","author":"Perez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0005","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/AAC.02429-13","article-title":"Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012","volume":"58","author":"Sader","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0006","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug- resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins \u2013 a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0008","unstructured":"United States Food and Drug Administration (2017) Code of Federal Regulations 21CFR184.1538."},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0009","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1074\/jbc.M006770200","article-title":"Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity","volume":"276","author":"Wiedemann","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jac\/dkp221","article-title":"A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species","volume":"64","author":"Piper","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.44.1.24-29.2000","article-title":"MICs of Mutacin B- Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens","volume":"44","author":"Mota-Meira","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jac\/dkf190","article-title":"Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci","volume":"50","author":"Brumfitt","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0013","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jam.13033","article-title":"Biomedical applications of nisin","volume":"120","author":"Shin","year":"2016","journal-title":"J Applied Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0014","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2591.2004.00846.x","article-title":"An in-vitro investigation of the antibacterial effect of nisin in root canals and canal wall radicular dentine","volume":"37","author":"Turner","year":"2004","journal-title":"Int Endod J"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0890334408317435","article-title":"The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation","volume":"24","author":"Fern\u00e1ndez","year":"2008","journal-title":"J Hum Lact"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0016","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1128\/AAC.00629-07","article-title":"Therapeutic effect of nisin Z on subclinical mastitis in lactating cows","volume":"51","author":"Wu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0017","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.3168\/jds.2007-0153","article-title":"Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows","volume":"90","author":"Cao","year":"2007","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0018","article-title":"Purified nisin intramammary treatment for subclinical mastitis in cows","year":"2017","journal-title":"Press release"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0019","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1128\/aem.57.12.3613-3615.1991","article-title":"Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria","volume":"57","author":"Stevens","year":"1991","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0020","doi-asserted-by":"crossref","first-page":"e76844","DOI":"10.1371\/journal.pone.0076844","article-title":"Value addition in the efficacy of conventional antibiotics by nisin against Salmonella","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0021","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3389\/fmicb.2016.01713","article-title":"Synergistic nisin-polymyxin combinations for the control of Pseudomonas biofilm formation","volume":"7","author":"Field","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0022","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00284-017-1375-y","article-title":"Synergistic antimicrobial activity between the broad spectrum bacteriocins garvicin KS and nisin, farnesol and polymyxin B against Gram-positive and Gram-negative bacteria","volume":"75","author":"Chi","year":"2018","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0023","unstructured":"CDC and FDA Antibiotic Resistance Bank. Atlanta (GA): CDC. [Feb. 25, 2019]."},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0024","unstructured":"MoBiTec GmbH, Germany (2015) NICE Nisin Kit [Nisin, 5% acetic acid]. Product information sheet. #VS-ELK01000-02."},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0025","series-title":"CLSI standard M07","article-title":"Performance Standards for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0026","series-title":"28th informational supplement","article-title":"Performance Standards for Antimicrobial Susceptibility Testing, M100","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0027","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.02328-12","article-title":"Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells","volume":"57","author":"Naghmouchi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0028","series-title":"NCCLS document M26-A","article-title":"Methods for Determining Bactericidal Activity of Antimicrobial agents; Approved guideline","year":"1999"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0029","unstructured":"European Food Safety Authority (EFSA) Panel on Food Additives and Nutrient Sources added to Food (ANS) (2017) Safety of nisin (E 234) as a food additive in the light of new toxicological data and the proposed extension of use. EFSA J 15:5063."},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/MMBR.00051-14","article-title":"Lantibiotic resistance","volume":"79","author":"Draper","year":"2015","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0031","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3168\/jds.S0022-0302(69)86771-8","article-title":"Inactivation of nisin by alpha-chymotrypsin","volume":"52","author":"Jarvis","year":"1969","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.ijantimicag.2019.03.009_bib0032","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1472-765X.2010.02948.x","article-title":"The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice","volume":"51","author":"Brand","year":"2010","journal-title":"Lett Appl Microbiol"},{"issue":"8","key":"10.1016\/j.ijantimicag.2019.03.009_bib0033","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/aem.61.8.2873-2878.1995","article-title":"Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering","volume":"61","author":"Rollema","year":"1995","journal-title":"Appl Environ Microbiol"},{"issue":"12","key":"10.1016\/j.ijantimicag.2019.03.009_bib0034","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00052-18","article-title":"Increasing the antimicrobial activity of nisin-based lantibiotics against Gram-negative pathogens","volume":"84","author":"Li","year":"2018","journal-title":"Appl Environ Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:37Z","timestamp":1760376757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919300627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0924857919300627"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}